Clinical Trial

Long-Term Immunogenicity of Envacgen® in Children

Name: Long-Term Immunogenicity of Envacgen® in Children — clinical trial record (NCT07568522)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study is designed to evaluate the long-term antibody titers of Envacgen® approximately 6 years after the first vaccination dose in participants who were aged 2 months to \<6 years at the time of enrollment in the CT-EV-31s study.

Trial Details

NCT Number	NCT07568522
Lead Sponsor	Medigen Vaccine Biologics Corp.
Conditions	Enterovirus 71 Human
Enrollment	220 participants
Start Date	2025-11-24
Primary Completion	2026-02-16 (estimated)
Study Completion	2026-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-05